Maternal and neonatal complications between post-COVID pregnant patient and normal patient: a tertiary care hospital-based comparative study
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20243168Keywords:
GDM, Birth weight, Post-COVID 19, PretermAbstract
Background: As the COVID-19 pandemic evolved the complications associated with acute infection have been well described. However, in the post-pandemic era, we must dwell on the obstetric sequelae of these infections. This study investigated the maternal and neonatal outcomes in post-COVID patients compared to normal pregnant women.
Methods: A prospective cohort study was designed where women who had a COVID-19 infection during pregnancy were compared with concomitant pregnant women without a COVID-19 diagnosis. Women were followed up from enrolment in the outpatient department until one-week post-partum, and data were collected.
Results: In this study, 201 women were included and divided into two groups. The women who had a COVID-19 infection during pregnancy had a significantly higher incidence of gestational diabetes mellitus (OR 3.6, 95% CI 1.0-12.6). There was also a significantly higher incidence of adverse perinatal complications (OR 1.5, 95% CI 1.1-2.0) particularly an increased rate of preterm delivery (OR 3.4, 95% CI 1.3-8.7) compared to the women who did not have a COVID-19 infection during pregnancy. Moreover, no significant differences existed in the measured outcomes when comparing women infected in the second trimester, to those infected in the third trimester.
Conclusions: The development of complications such as preterm delivery and gestational diabetes mellitus among women after a COVID-19 infection during pregnancy underscores the necessity for close monitoring of such patients and the promotion of strategies to prevent infection.
References
Chen Y, Li Z, Zhang YY, Zhao WH, Yu ZY. Maternal health care management during the outbreak of coronavirus disease 2019. J Med Virol. 2020;92(7):731-9.
Zaigham M, Andersson O. Maternal and perinatal outcomes with COVID-19: A systematic review of 108 pregnancies. Acta Obstet Gynecol Scand. 2020;99(7):823-9.
McClymont E, Albert AY, Alton GD, Boucoiran I, Castillo E, Fell DB, et al. Association of SARS-CoV-2 infection during pregnancy with maternal and perinatal outcomes. JAMA. 2022;327(20):1983-91.
Kumar R, Yeni CM, Utami NA, Masand R, Asrani RK, Patel SK, et al. SARS-CoV-2 infection during pregnancy and pregnancy-related conditions: Concerns, challenges, management and mitigation strategies-a narrative review. J Infect Public Health. 2021;14(7):863-75.
Allotey J, Fernandez S, Bonet M, Stallings E, Yap M, Kew T, et al. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis. BMJ. 2020;370:m3320.
Staffolani S, Iencinella V, Cimatti M, Tavio M. Long COVID-19 syndrome as a fourth phase of SARS-CoV-2 infection. Infez Med. 2022;30(1):22-9.
Cuñarro-López Y, Cano-Valderrama Ó, Pintado-Recarte P, Cueto-Hernández I, González-Garzón B, García-Tizón S, et al. Maternal and Perinatal Outcomes in Patients with Suspected COVID-19 and Their Relationship with a Negative RT-PCR Result. J Clin Med. 2020;9(11):3552.
Afshar Y, Gaw SL, Flaherman VJ, Chambers BD, Krakow D, Berghella V, et al. Clinical presentation of Coronavirus Disease 2019 (COVID-19) in pregnant and recently pregnant people. Obstet Gynecol. 2020;136(6):1117.
Radan AP, Fluri MM, Nirgianakis K, Mosimann B, Schlatter B, Raio L, et al. Gestational diabetes is associated with SARS-CoV-2 infection during pregnancy: A case-control study. Diabetes Metab. 2022;48(4):101351.
Rhou YJJ, Elhindi J, Melov SJ, Cheung NW, Pasupathy D, the Western Sydney COVID-19 Pregnancy Study Group. Indirect effects of the COVID-19 pandemic on risk of gestational diabetes and factors contributing to increased risk in a multiethnic population: a retrospective cohort study. BMC Pregnancy Childbirth. 2023;23(1):341.
Metz TD, Clifton RG, Hughes BL, Sandoval GJ, Grobman WA, Saade GR, et al. Association of SARS-CoV-2 infection with serious maternal morbidity and mortality from obstetric complications. JAMA. 2022;327(8):748-59.
Villar J, Ariff S, Gunier RB, Thiruvengadam R, Rauch S, Kholin A, et al. Maternal and neonatal morbidity and mortality among pregnant women with and without COVID-19 infection: The INTERCOVID Multinational Cohort Study. JAMA Pediatr. 2021;175(8):817-26.